---
title: "Kingchem shareholders Blue Zone Fund plan to reduce their holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240373989.md"
description: "According to the Zhitong Finance APP, Kingchem announced that its shareholder Blue Economy Zone Industrial Investment Fund (Limited Partnership) (referred to as \"Blue Zone Fund\") plans to reduce its holdings in the company by no more than 3.612 million shares (accounting for 3% of the company's total share capital) through centralized bidding and block trading"
datetime: "2025-05-15T12:03:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240373989.md)
  - [en](https://longbridge.com/en/news/240373989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240373989.md)
generator: "portal-rs"
---

# Kingchem shareholders Blue Zone Fund plan to reduce their holdings by no more than 3%

According to the Zhitong Finance APP, Kingchem (301509.SZ) announced that its shareholder, Blue Economic Zone Industrial Investment Fund (Limited Partnership) (referred to as "Blue Zone Fund"), plans to reduce its holdings in the company by no more than 3.612 million shares (accounting for 3% of the company's total share capital) through centralized bidding and block trading

### Related Stocks

- [301509.CN](https://longbridge.com/en/quote/301509.CN.md)

## Related News & Research

- [NRED Identifies Stronger Untested IP Targets Beyond 1.67% Copper Trench Mineralization at Wilmac | NREDF Stock News](https://longbridge.com/en/news/296612079.md)
- [08:31 ETTiger Group Offers Lab Equipment, Plastics Inventory and More from Grow Materials, LLC](https://longbridge.com/en/news/296491453.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**